Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Intravenous stopcocks are being used for decades to deliver infusion therapy in patients. This device is used to direct the fluid flow through an infusion system while allowing multiple fluids to be connected. The device is featured with three important components, namely body, handle, and luer-locking collar, which is fixed or rotating. Growing attention to patient safety and introduction to new technologies are driving demand for safety products such as intravenous stopcock. Due to rising demand for such safety products, key players are actively involved in research activities to introduce different product designs. For instance, Mediplus India Ltd. offers three way stopcock with extension tube that can be used with various infusion devices in order to allow for attachment with medical device.

According to a study published in the National Library of Medicine in 2018, intravenous stopcocks are being used to deliver infusion therapy in all age patients for decades. This medical device is used in all healthcare settings. In 2011, it was stated by the Infusion Nursing Standards of Practice that the use of stopcocks was not recommended earlier because of the risk of infection. Furthermore, in 2016, Infusion Therapy Standards of Practice called for similar avoidance of its use, except added that a stopcock with an integral NC (Needleless Connector) should be chosen to lessen stopcock contamination.

Various companies in the Asia Pacific region are adopting organic as well as inorganic strategies to hold a strong market position. Some of the activities undertaken by the companies, which have promoted the market growth, include product launches and partnerships. For instance, in December 2018, Merit Medical Systems, Inc. launched its Prelude Ideal, which is specially designed for use in radial access procedures. This product utilizes hydrophilic coating to the tip of the sheath tubing to reduce the risk of radial artery spasm.

Intravenous Stopcock Market - Impact Analysis of COVID-19

The intravenous stopcock market is witnessing progressive growth due to the outbreak of the COVID-19 virus. This is mainly because the intravenous stopcocks are cost-effective medical devices, which are gaining attention among healthcare professionals and patients, as it is used as a component of infusion systems. It is estimated that the intravenous stopcocks will play a major role post the pandemic stress, which will aid the market to grow exponentially during the forecast period.

The comprehensive version of the report will include COVID-19’s impact and the projected changes on the future outlook of the industry, by taking into account the social, economical, political, and technological parameters.

The intravenous stopcock market is estimated to be valued at US$ 338.62 million in 2020 and is expected to exhibit a CAGR of 7.73% during the forecast period (2020-2027).

Figure 1: Intravenous Stopcock Market Share (%) Analysis, By Type, 2020

Intravenous Stopcock  | Coherent Market Insights

The development of novel products and mergers & acquisitions by industry players are expected to drive growth of the intravenous stopcock market.

Key players in the market are involved in developing novel products and mergers & acquisitions, collaborations, joint ventures, and partnerships to strengthen their position in the market. Strategic collaborations among key players is expected to considerably drive the market growth and create growth opportunities for the intravenous stopcock market during the forecast period.

For instance, in February 2017, ICU Medical Inc. completed the acquisition of Hospira Infusion Systems (HIS) business. The Hospira Infusion Systems business includes intravenous (IV) pumps and solutions, and also devices that makes ICU Medical one of the leading global infusion therapy company.

Furthermore, the market players are involved in launching new programs for patient safety. For instance, in April 2019, Becton, Dickson and Company (BD) launched a new program for patient safety in hospitals, called as PRIME (Preventing Risks of Infections and Medication Errors in IV Therapy). PRIME is developed in partnership with the Joint Commission International (JCI) for patient safety and aimed to address the challenges in a hospital setting regarding medical safety and infection prevention.

request-sample

Intravenous Stopcock Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 338.6 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 7.73% 2027 Value Projection: US$ 570.4 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Three-way Stopcock, Four-way Intravenous Stopcock.
  • By Application: Pressure Monitoring, Infusion Therapy.
  • By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others.
Companies covered (8):

BD, Global Medikit Limited, Nordson Corporation, SCW Medicath Ltd., Fresenius Kabi AG, Smith’s Medical, Braun Medical Inc., Terumo Medical Corporation, ARGON MEDICAL, Baxter, Bound Tree Medical, Mediprim, Fresenius Kabi, Neotec Medical Industries, and ICU Medical

Growth Drivers:
  • Growing attention to patient safety
  • Introduction to new technologies
Restraints & Challenges:
  • Risk of contamination during product usage

Intravenous Stopcock Market - Restraints

Stopcocks possess a risk of contamination during its usage. This has cautioned healthcare facilities to follow strict usage guidelines and mitigate the risk through use of needle-free connectors. These alternative products are expected to hamper growth of the intravenous stopcock market. Lack of skilled professionals in emerging economies such as the Middle East & Africa and the Asia Pacific is projected to be another reason for the slow growth of intravenous stopcock market. Moreover, leakage of drugs from the stopcocks is also expected to restrict growth of the intravenous stopcock market during the forecast period.

Intravenous Stopcock Market - Regional Analysis

North America region accounted for the largest share in the intravenous stopcock market in 2019, owing to the new product introductions coupled with rising demand for advanced medical treatment. In addition, rising prevalence of chronic diseases will fuel the regional market growth to a great extent. According to the National Health Council (NHC), around 133 million Americans are affected by chronic diseases every year and this number is estimated to increase to 157 million by the end of 2020. Moreover, industry players are adopting strategies such as joint ventures and acquisitions to strengthen their position in the global market. This is also contributing to growth of the market in North America region.

Europe is also expected to witness significant growth in the global intravenous stopcock market, owing to rising attention towards patient safety and developments by key industry players in the region. Moreover, industry players are implementing organic development strategies widely, which is aiding in significant growth of the market. For instance, in February 2016, Marvelous (MRLVS) stopcock was launched by Elcam Medical, which is a three-way stopcock made by Makrolon, a high-performance plastic by Covetsro.

Figure 2: Intravenous Stopcock Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Intravenous Stopcock  | Coherent Market Insights

Intravenous Stopcock Market - Competitive Landscape

Key players operating in the intravenous stopcock market include BD, Global Medikit Limited, Nordson Corporation, SCW Medicath Ltd., Fresenius Kabi AG, Smith’s Medical, Braun Medical Inc., Terumo Medical Corporation, ARGON MEDICAL, Baxter, Bound Tree Medical, Mediprim, Fresenius Kabi, Neotec Medical Industries, and ICU Medical.

Stopcock is a medical device and a type of ball valve that is used along with the set of intravenous administration. The fluid delivery is regulated to the vascular system with the help of an intravenous stopcock. Stopcocks are of different types such as burette stopcocks, vacuum stopcocks, and needle valve. This medical device is mainly designed to control the flow of gas or liquid through the use of an off/on diverter.

Market Dynamics

A surge in the use of intravenous stopcocks for instilling solutions from catheters and for regular nursing procedures is expected to drive the intravenous stopcock market growth in the near future. Moreover, the rise in geriatric population and increasing prevalence of chronic diseases such as cancer and diabetes are other factors boosting the market growth. According to the World Health Organization (WHO), it is expected that there will be around 700 million people living with diabetes by 2045 globally.

The intravenous stopcock is a cost-effective medical equipment and is gaining popularity amongst manufacturers due to growing technological advancements, which is expected to fuel the market growth during the forecast period.

However, rising concerns related to the risk of infection due to stopcocks is expected to hamper the market growth over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global intravenous stopcock market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global intravenous market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
  • Key players covered as a part of this study include BD, Global Medikit Limited, Nordson Corporation, SCW Medicath Ltd., Fresenius Kabi AG, Smith’s Medical, Braun Medical Inc., Terumo Medical Corporation, ARGON MEDICAL, Baxter, Bound Tree Medical, Mediprim, Fresenius Kabi, Neotec Medical Industries, and ICU Medical
  • Insights from this report would allow marketers and management authorities of companies to make an informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global intravenous stopcock market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for intravenous stopcock market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

  • Global Intravenous Stopcock Market, By Type:
    • Three-way Stopcock
    • Four-way Stopcock
  • Global Intravenous Stopcock Market, By Application:
    • Pressure Monitoring
    • Infusion Therapy
  • Global Intravenous Stopcock Market, By End User:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
    • Others
  • Global Intravenous Stopcock Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Type:
        • Three-way Stopcock
        • Four-way Stopcock
      • By Application:
        • Pressure Monitoring
        • Infusion Therapy
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
        • Others
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Type:
        • Three-way Stopcock
        • Four-way Stopcock
      • By Application:
        • Pressure Monitoring
        • Infusion Therapy
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
        • Others
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Type:
        • Three-way Stopcock
        • Four-way Stopcock
      • By Application:
        • Pressure Monitoring
        • Infusion Therapy
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
        • Others
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Type:
        • Three-way Stopcock
        • Four-way Stopcock
      • By Application:
        • Pressure Monitoring
        • Infusion Therapy
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
        • Others
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Type:
        • Three-way Stopcock
        • Four-way Stopcock
      • By Application:
        • Pressure Monitoring
        • Infusion Therapy
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
        • Others
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Type:
        • Three-way Stopcock
        • Four-way Stopcock
      • By Application:
        • Pressure Monitoring
        • Infusion Therapy
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
        • Others
  • Company Profiles
    • BD
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Global Medikit Limited
    • Nordson Corporation
    • SCW Medicath Ltd.
    • Fresenius Kabi AG
    • Smiths Medical
    • Braun Medical Inc.
    • Terumo Medical Corporation
    • ARGON MEDICAL
    • Baxter
    • Bound Tree Medical
    • Mediprim
    • Fresenius Kabi
    • Neotec Medical Industries
    • ICU Medical

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Technological Advancements in Intravenous Stopcock
    • Key Developments
    • Acquisition, Collaborations & Partnerships
    • Epidemiology
  4. Global Intravenous Stopcock Market, Impact of Coronavirus (COVID-19) Pandemic
    • Pre-COVID situation
    • Post-COVID demand
    • Need for Intravenous Stopcock
    • Recommendations and Guidelines by Regulatory Bodies
  5. Global Intravenous Stopcock Market, By Type, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Three-way Stopcock
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Four-way Intravenous Stopcock
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  6. Global Intravenous Stopcock Market, By Application, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Pressure Monitoring
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Infusion Therapy
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  7. Global Intravenous Stopcock Market, By End User, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Specialty Clinics
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Others
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  8. Global Intravenous Stopcock Market, By Region, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027(%)
      • Y-o-Y Growth Analysis, By Region, 2017 –2027
      • Regional Trends
    • North America
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
  9. Competitive Landscape
    • Company Profiles
      • BD
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Global Medikit Limited
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Nordson Corporation
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • SCW Medicath Ltd.
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Fresenius Kabi AG
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Smith’s Medical
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Braun Medical Inc.
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Terumo Medical Corporation
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • ARGON MEDICAL
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Baxter
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Bound Tree Medical
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Mediprim
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Fresenius Kabi
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Neotec Medical Industries
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • ICU Medical
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 24 market data tables and 26 figures on "Global Intravenous Stopcock Market” - Forecast to 2027”

Frequently Asked Questions

The CAGR of the intravenous stopcock market is expected to be 7.73% during the forecast period (2020-2027).
The value of the global market for intravenous stopcock is estimated to be valued at US$ 338.6 million in 2020.
The prominent players in the intravenous stopcock market across the globe are BD, Global Medikit Limited, Nordson Corporation, SCW Medicath Ltd., Fresenius Kabi AG, Smith’s Medical, Braun Medical Inc., Terumo Medical Corporation, ARGON MEDICAL, Baxter, Bound Tree Medical, Mediprim, Fresenius Kabi, Neotec Medical Industries, and ICU Medical.
The intravenous stopcock market is expected to be valued at US$ 570.4 million in 2027.
The major region in the global intravenous stopcock market is North America.
An increasing demand for intravenous stopcock, owing to its use in instilling solutions from catheters and regular nursing procedures is a major factor driving the market growth.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner